Related Experiment Video
Updated: Jul 3, 2026
16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Resistance mechanisms in HCV: from evolution to intervention
1Partners AIDS Research Center, Massachusetts General Hospital/Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA. akim1@partners.org
Expert Review of Anti-Infective Therapy
|July 30, 2008
Summary
Hepatitis C virus (HCV) drug resistance emerges due to its error-prone replication, necessitating an understanding of evolutionary mechanisms. This review examines resistance profiles to new HCV therapies, crucial for future treatment strategies.
Area of Science:
- Virology
- Evolutionary Biology
- Pharmacology
Background:
- Recent advancements in understanding the Hepatitis C virus (HCV) life cycle and viral proteins have led to targeted antiviral therapies.
- These direct-acting antivirals (DAAs) effectively inhibit HCV replication, showing high efficacy in clinical trials.
Purpose of the Study:
- To discuss the evolutionary mechanisms driving drug resistance in HCV.
- To provide an overview of resistance profiles against current HCV protease and polymerase inhibitors.
- To explore the implications of drug resistance for future HCV treatment strategies.
Main Methods:
- Review of current scientific literature on HCV evolution and drug resistance.
- Analysis of clinical trial data regarding the efficacy and resistance patterns of DAAs.
- Examination of viral quasispecies complexity and its role in adaptation.
Main Results:
- HCV's error-prone replication generates diverse quasispecies, facilitating rapid adaptation and the selection of drug-resistant variants.
- Specific resistance profiles have been identified for emerging HCV protease and polymerase inhibitors.
- Drug resistance is a significant challenge, mirroring issues seen with HIV and HBV treatments.
Conclusions:
- Understanding the evolutionary dynamics of HCV is critical for overcoming drug resistance.
- Future HCV treatment strategies must account for and proactively manage the development of resistant viral strains.
- Continued research into resistance mechanisms and novel therapeutic approaches is essential for sustained HCV eradication.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...